Akero Therapeutics Inc (AKRO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -1451.976 | -211.374 | -40.651 | -38.501 | -42.986 | -40.583 | -32.398 |
Return on Equity (%) | 209.334 | 301.87 | -111.043 | -40.888 | -47.112 | -45.205 | -35.216 |
Return on Invested Capital (%) | -2194.231 | -36.641 | -44.878 | -41.405 | -47.231 | -45.635 | -39.424 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.626 | 101.781 | 4.506 | 7.447 | 4.849 | 6.968 | 9.609 |
Earnings Per Share | -6.864 | -111.883 | -1.532 | -2.28 | -2.89 | -2.391 | -2.724 |
Cash Per Share | 0.859 | 103.367 | 2.268 | 5.389 | 4.315 | 5.33 | 4.204 |
Working Capital Per Share | 0.598 | 101.754 | 4.504 | 7.433 | 4.83 | 7.171 | 9.708 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -6.557 | -111.176 | -1.532 | -2.28 | -2.89 | -2.391 | -2.724 |
EBITDA Per Share | -6.557 | -111.176 | -1.532 | -2.28 | -2.89 | -2.391 | -2.724 |
Free Cash Flow Per Share | -6.864 | -111.883 | -1.532 | -2.276 | -2.891 | -2.391 | -2.725 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 696k | 735k | 28,57M | 34,74M | N/A | 46,87M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 46,66M | 46,87M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,14B |
Ratio cours/bénéfice | -14,79 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 9,58 |
Ratio prix/valeur comptable | 4,19 |
Rendement de dividende | - |
Actions en circulation | 69,43M |
Volume moyen (1 semaine) | 492,62k |
Volume moyen (1 mois) | 464,88k |
Variation sur 52 semaines | 170,77% |
Plus haut sur 52 semaines | 37,00 |
Plus bas sur 52 semaines | 11,92 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales